Burkholderia pseudomallei: Melioidosis, Pathogenesis, Diagnosis, Treatment

A rice farmer in Thailand with poorly controlled diabetes comes to hospital during the monsoon season with a high fever and cough that have worsened over a week. A chest x-ray shows pneumonia, and blood cultures grow a gram-negative organism. He recalls no injury, but he wades barefoot through flooded fields every day. The clues line up: heavy rain, wet soil, bare feet, and diabetes, the strongest risk factor of all. An organism living in that soil has entered his body and taken advantage of his weakened defenses. This is melioidosis, caused by Burkholderia pseudomallei, a disease that can also lie silent for years before it appears.

Introduction

Burkholderia pseudomallei causes melioidosis (also called Whitmore's disease), a serious and often life-threatening infection. A closely related organism, B. mallei, causes glanders, a similar disease chiefly of horses and, rarely, humans.

One idea organizes the whole topic: B. pseudomallei lives freely in soil and water in the tropics, so people are infected from the environment, and it does its most serious damage in people whose defenses are weakened, above all by diabetes. It is also an intracellular organism that can survive quietly in the body and reactivate years later, which is why melioidosis has been nicknamed the "Vietnamese time-bomb." Because of its potential for aerosol spread, the CDC classifies B. pseudomallei (and B. mallei) as a Category B bioterrorism agent.

Figure: B.pseudomallei on Blood Agar

Properties

• Aerobic, non-fermentative gram-negative bacillus (it does not ferment carbohydrates).
• Gram-negative rod with a characteristic bipolar or "safety pin" appearance (the ends stain more darkly than the middle), best seen with methylene blue.
• Motile (an important difference from Pseudomonas-like non-fermenters it can be confused with, and from B. mallei, which is non-motile)
• It is a member of the family Burkholderiaceae, which includes other genera (Cupriavidus, Lautropia, Pandoraea, and Ralstonia). More than 87 species of Burkholderia have been identified. Other medically important species are  Burkholderia cepacia, Burkholderia gladioli, etc.
• Burkholderia pseudomallei is a saprophyte of soil and water and is spread to humans and animals through direct contact with contaminated sources.

Figure: Flow diagram to rule out or refer B. mallei. Image source: Laboratory Response Network (LRN)

Pathogenesis

B. pseudomallei is a saprophyte of soil and water in endemic regions. People are infected from the environment by three routes:

• Inoculation through skin breaks during contact with contaminated soil or water (for example, barefoot farming). This is the most common route.
• Inhalation of contaminated dust or aerosolized water droplets, which is more likely during heavy rain and is linked to more severe disease. This is why cases rise sharply in the monsoon season.
• Ingestion of contaminated water.

Person-to-person spread is very rare. Because exposure to soil and water is so common in endemic areas but disease is much less common, host factors are what decide who becomes ill.

Why diabetes matters so much

Melioidosis is strongly an opportunistic infection. The single most important risk factor is diabetes mellitus, and other risks include hazardous alcohol use, chronic kidney disease, chronic lung disease, and any cause of weakened immunity. Only a minority of patients have no identifiable risk factor. The reason is that B. pseudomallei survives inside host cells, so an intact cellular immune response is needed to control it, and conditions like diabetes impair exactly that response. For an audience in endemic South and Southeast Asia, this is the key public-health message: melioidosis is above all a disease of people with diabetes exposed to soil and water.

Virulence Factors

B. pseudomallei is a facultative intracellular pathogen, and its virulence factors let it enter cells, survive inside them, and spread from cell to cell.

• Polysaccharide capsule: antiphagocytic; it resists being engulfed and killed, and helps the organism survive in the blood.
• Type III secretion system: a molecular "injection" apparatus. It injects bacterial proteins into the host cell that let B. pseudomallei escape from the phagosome into the cytosol, where it multiplies safely, much like other intracellular pathogens.
• Actin-based motility and cell-to-cell spread: once in the cytosol, the organism hijacks the host cell's actin to propel itself and can fuse neighboring cells together (forming multinucleated giant cells), allowing it to spread directly from cell to cell without going back outside. This intracellular spreading is central to how it disseminates and hides.
• Tissue-damaging enzymes and toxins: proteases, lipases, and other secreted products damage host tissue and aid invasion, contributing to the abscesses that characterize the disease.

Putting it together: the organism enters through skin, lungs, or gut, is taken up by host cells, escapes into the cytosol using its type III secretion system, multiplies, and spreads cell to cell using actin. Its capsule protects it in the blood so it can disseminate widely and seed abscesses in many organs. Because it lives inside cells, it can persist quietly for long periods and reactivate later, and clearing it depends on cell-mediated immunity, which is why diabetes and other immune-weakening conditions are such strong risk factors.

Clinical Manifestations

Melioidosis is mainly a disease of the tropics, especially Southeast Asia (Thailand, Vietnam, Cambodia, Laos, Malaysia, Myanmar) and northern Australia, and it is increasingly recognized in South Asia and other tropical regions.

The incubation period varies enormously, from a few days to many years, because the organism can stay dormant and reactivate later. Melioidosis is a great mimic: it ranges from a mild flu-like illness or a single skin abscess to severe pneumonia and overwhelming bloodstream infection. Two features run through it: a strong tendency to form abscesses in many organs, and a high death rate in severe disease if it is not treated promptly and correctly.

Acute Localized Infection: Infection is localized as a nodule and results from inoculation through a break in the skin. A patient generally presents with:

• Localized pain or swelling
• Fever
• Ulceration
• Abscess

Pulmonary Infection: This form of the disease can produce a clinical picture of mild bronchitis to severe pneumonia. Commonly seen signs/symptoms are:

• Cough
• Chest pain
• High fever
• Headache
• Anorexia

Acute Bloodstream Infection (septicemic melioidosis): this is the most severe form and carries the highest mortality. It occurs especially in patients with underlying conditions, above all diabetes, and also chronic kidney disease and other causes of weakened immunity. The symptoms generally include:

• Fever
• Headache
• Respiratory distress
• Abdominal discomfort
• Joint pain
• Disorientation

Chronic Suppurative Infection: Chronic melioidosis is a disseminated infection that involves various organs of the body such as joints, viscera, skin, brain, liver, lungs, bones, and spleen.

Laboratory Diagnosis

Sample

Figure: B. pseudomallei in Gram-stain (image source-Ian Martin, idmic-net).

Sample depends on the site of infection. Sputum and purulent discharge from the lesion are commonly used.

Microscopy and Staining

B. pseudomallei is a Gram-negative bacillus that typically exhibits a bipolar or safety pin appearance, which is better appreciated when stained with methylene blue.

Culture

B. pseudomallei is an aerobe that grows on ordinary media such as nutrient agar, blood agar, and MacConkey agar. Colonies are often dry, rough, and wrinkled (corrugated), which can resemble Pseudomonas stutzeri. Ashdown's agar is the selective medium: on it, B. pseudomallei forms characteristic dry, wrinkled, purple-pink colonies over several days.

An important safety point: because laboratory staff can be infected, the laboratory must be alerted whenever melioidosis is suspected, and the organism is handled under the appropriate biosafety conditions. It is also frequently misidentified by automated systems, so clinical suspicion matters.

Figure: Burkholderia pseudomallei on Ashdown’s medium(image source: Gavin Koh ref-2)

Important properties that differentiate it from Pseudomonas stutzeri include

• Gelatin liquefaction positive
• Utilizes arginine
• Positive for intracellular poly-β-hydroxybutyrate (PHB).

Latex agglutination test: Culture can be confirmed by latex agglutination test using specific antisera.

Antigen detection

Rapid agglutination tests for detecting B. pseudomallei antigen in urine are available.

Serology

Antibodies against B. pseudomallei can be detected and measured in blood.

Treatment of melioidosis

Two things make treatment distinctive, and both are high-yield.

First, B. pseudomallei is intrinsically resistant to many common antibiotics (including many penicillins, older cephalosporins, gentamicin, and others). This narrows the choices sharply and is why empirical "blind" antibiotics for sepsis can fail if melioidosis is not considered.

Second, treatment has two phases, and skipping the second phase leads to relapse. This two-phase structure is the single most important thing to remember about melioidosis treatment.

• Intensive phase: intravenous therapy to control the acute infection. The drug of choice is ceftazidime or a carbapenem (meropenem or imipenem).
• Eradication phase: a prolonged course of oral therapy to clear organisms hiding inside cells and prevent relapse. The first-choice drug is trimethoprim-sulfamethoxazole (co-trimoxazole), with co-amoxiclav as an alternative (for example, in pregnancy).

The eradication phase must be continued for months. This is because the organism survives inside cells, so a short course leaves hidden bacteria that cause relapse, the reason melioidosis can recur. Prompt, correct treatment greatly reduces what is otherwise a very high mortality in severe disease.

Prevention, especially for people with diabetes in endemic areas, focuses on avoiding exposure: wearing boots and gloves for farming and soil or water contact, and staying out of heavy rain and floodwater aerosols where possible. There is no licensed vaccine, though several are in development.

For the related intracellular Category A/B select agent that also causes pneumonic and disseminated disease, see the article on Francisella tularensis.

How to Remember

Key exam facts in one table

Where Students Get Confused

References and Further Readings

1. Tille, P. M. (2022). Bailey & Scott's Diagnostic Microbiology (15th ed.). Elsevier.
2. Procop, G. W., & Koneman, E. W. (2017). Koneman's Color Atlas and Textbook of Diagnostic Microbiology (7th ed.). Wolters Kluwer.
3. Carroll, K. C., Pfaller, M. A., et al. (2020). Murray's Medical Microbiology (9th ed.). Elsevier.
4. Wiersinga, W. J., Virk, H. S., Torres, A. G., et al. (2018). Melioidosis. Nature Reviews Disease Primers, 4, 17107.
5. Centers for Disease Control and Prevention. Melioidosis: clinical overview. CDC (current version).